Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DACLATASVIR: 5,602 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
5,602
Total FAERS Reports
581 (10.4%)
Deaths Reported
1,637
Hospitalizations
5,602
As Primary/Secondary Suspect
283
Life-Threatening
91
Disabilities
Apr 13, 2016
FDA Approved
Discontinued
Status

FDA Application: 206843 ·

Patent Expires: Jun 13, 2031 · First Report: 2000 · Latest Report: 20230401

What Are the Most Common DACLATASVIR Side Effects?

#1 Most Reported
Fatigue
510 reports (9.1%)
#2 Most Reported
Hepatocellular carcinoma
419 reports (7.5%)
#3 Most Reported
Headache
411 reports (7.3%)

All DACLATASVIR Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Fatigue 510 9.1% 35 48
Hepatocellular carcinoma 419 7.5% 71 126
Headache 411 7.3% 28 59
Hepatitis c 400 7.1% 6 29
Drug ineffective 385 6.9% 8 23
Treatment failure 310 5.5% 5 15
Nausea 287 5.1% 33 71
Anaemia 251 4.5% 42 108
Ascites 205 3.7% 40 115
Off label use 199 3.6% 9 72
Insomnia 183 3.3% 12 26
Diarrhoea 177 3.2% 24 49
Hepatic failure 170 3.0% 86 65
Hepatic encephalopathy 165 3.0% 48 101
Genotype drug resistance test positive 164 2.9% 1 4
Acute kidney injury 148 2.6% 54 90
Pyrexia 142 2.5% 17 93
Asthenia 135 2.4% 12 47
Death 135 2.4% 135 31
Dyspnoea 126 2.3% 24 63

Who Reports DACLATASVIR Side Effects? Age & Gender Data

Gender: 39.7% female, 60.3% male. Average age: 58.1 years. Most reports from: US. View detailed demographics →

Is DACLATASVIR Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2012 8 0 7
2013 18 6 15
2014 365 59 220
2015 996 107 563
2016 1,229 104 358
2017 348 33 112
2018 54 9 17
2019 30 2 8
2020 6 0 5
2021 8 0 2
2022 6 0 4
2023 4 0 0

View full timeline →

What Is DACLATASVIR Used For?

IndicationReports
Hepatitis c 2,520
Chronic hepatitis c 2,063
Product used for unknown indication 613
Hepatic cirrhosis 140
Hepatitis c virus test 84
Hepatitis c virus test positive 31
Hiv infection 31
Hepatocellular carcinoma 25
Hepatitis 21
Chronic hepatitis 19

DACLATASVIR vs Alternatives: Which Is Safer?

DACLATASVIR vs DACLIZUMAB DACLATASVIR vs DACOMITINIB DACLATASVIR vs DACTINOMYCIN DACLATASVIR vs DALBAVANCIN DACLATASVIR vs DALFAMPRIDINE DACLATASVIR vs DALTEPARIN DACLATASVIR vs DAMOCTOCOG ALFA PEGOL DACLATASVIR vs DANAPAROID DACLATASVIR vs DANAZOL DACLATASVIR vs DANICOPAN

Official FDA Label for DACLATASVIR

Official prescribing information from the FDA-approved drug label.